1. Justin Sun: Has filed a lawsuit against World Liberty Financial in California Federal Court;
2. SBF's early $200,000 investment in Cursor's funding round, if equity is not sold, is currently worth approximately $3 billion;
3. Iran's Permanent Representative to the UN: The US lifts sanctions and resumes negotiations;
4. Etherealize: Ethereum may surge to $250,000, the "productive money" narrative draws attention;
5. Expert: Trump's hostility towards Iran has a long history, but overthrowing the Iranian regime is far from easy;
6. Analyst: Bitcoin returns to a key cost line, short-term buyers have basically broken even;
7. HIVE Digital completes $115 million zero-coupon convertible note financing;
8. Venus attacker transfers 2,301 ETH, then launders it in batches through Tornado Cash;
9. Singapore to optimize crypto capital regulation: Public chain assets may no longer be uniformly classified as high-risk;
10. Analyst: AI sector Q1 funding reaches $242 billion, but capital is highly concentrated in a few "mega funding rounds".
Svmuu Noon News
Source:Odaily · Source Link
Disclaimer: This content reflects only the author’s personal views and does not constitute any investment or financial advice. If you discover any content that violates regulations,Click to Report
24H Trending
-
1
Billionaire investor Chase Coleman’s Tiger Global fund disclosed in its latest 13F filing that its top five growth stocks are all focused on AI infrastructure, including TSMC, NVIDIA, Amazon, Meta, and Google.
-
2
What Is CVP? An In-Depth Analysis of the PowerPool Ecosystem and the Investment Value of Its Token, CVP
-
3
Analysis of CRYSTAL’s Value and Investment Potential: An Examination of Multiple Projects and Risk Assessment
-
4
What Is JGN? Analysis of the JGN (Sword Saint Coin) Project’s Positioning, Features, and Value
-
5
Iran-linked exchange Shelbit allegedly sent $676 million to Binance in sanctions-evasion operation, Reuters reports
-
6
Analysis: The State Street Healthcare ETF (XLV) has an expense ratio of 0.08% and a diversified portfolio, while the Invesco Biotechnology ETF (PBE) has an expense ratio of 0.58% and focuses on small-cap stocks; PBE is up 10.2% year-to-date, outperforming XLV.
-
7
Analysis Compares Healthcare ETFs: Invesco Nasdaq Biotech ETF (IBBQ) Saw 45.5% One-Year Return, Outperforming State Street Healthcare Select Sector SPDR ETF (XLV)
-
8
Ethereum Recent Rebound: Price Breaks Above $1,970, but Multiple Risks Remain
-
9
Analysis: Vanguard Small-Cap Growth ETF (VBK) up 21% YTD 2026, Outperforming Large-Cap Growth ETF (VONG) at 0.3% YTD
-
10
QUARTZ Coin Analysis: An Overview of the Sandclock (QUARTZ) and Unique Network’s Quartz (QTZ) Projects
Markets Today
Recommended Reading







